The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Veen, N. D.
* Articles by Kahn, R. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Veen, N. D.
* Articles by Kahn, R. S.
Related Collections
* Gender
* Schizophrenia Spectrum Disorders
* Cannabis
*Related Article
Am J Psychiatry 161:501-506, March 2004
© 2004 American Psychiatric Association


Article

Cannabis Use and Age at Onset of Schizophrenia

Natalie D. Veen, M.D., Jean-Paul Selten, M.D., Ph.D., Ingeborg van der Tweel, Wilma G. Feller, Hans W. Hoek, M.D., Ph.D., and René S. Kahn, M.D., Ph.D.

OBJECTIVE: The purpose of the study was to assess the independent influences of gender and cannabis use on milestones of early course in schizophrenia. METHOD: In this population-based, first-contact incidence study conducted in The Hague, the Netherlands, patients (N=133) were interviewed with the Comprehensive Assessment of Symptoms and History, and key informants were interviewed with the Instrument for the Retrospective Assessment of the Onset of Schizophrenia. Milestones of early course were 1) first social and/or occupational dysfunction, 2) first psychotic episode, and 3) first negative symptoms. RESULTS: Male patients were significantly younger than female patients at first social and/or occupational dysfunction, first psychotic episode, and first negative symptoms. Cannabis-using patients were significantly younger at these milestones than were patients who did not use cannabis. Multivariate analyses showed that cannabis use, but not gender, made an independent contribution to the prediction of age at first psychotic episode: male cannabis users were a mean of 6.9 years younger at illness onset than male nonusers. In contrast, age at first social and/or occupational dysfunction and the risk of developing negative symptoms before the first contact with a physician for treatment of possible psychotic disorder were predicted by gender, but not by cannabis use. CONCLUSIONS: The results indicate a strong association between use of cannabis and earlier age at first psychotic episode in male schizophrenia patients. Additional studies examining this possibly causal relationship are needed.


Related Article:

In This Issue
Am J Psychiatry 2004 161: A86. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
M. Rais, W. Cahn, N. Van Haren, H. Schnack, E. Caspers, H. Hulshoff Pol, and R. Kahn
Excessive Brain Volume Loss Over Time in Cannabis-Using First-Episode Schizophrenia Patients
Am J Psychiatry, April 1, 2008; 165(4): 490 - 496.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
S. Archie, B. R. Rush, N. Akhtar-Danesh, R. Norman, A. Malla, P. Roy, and R. B. Zipursky
Substance Use and Abuse in First-Episode Psychosis: Prevalence Before and After Early Intervention
Schizophr Bull, November 1, 2007; 33(6): 1354 - 1363.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
J. H. BARNETT, U. WERNERS, S. M. SECHER, K. E. HILL, R. BRAZIL, K. MASSON, D. E. PERNET, J. B. KIRKBRIDE, G. K. MURRAY, ED. T. BULLMORE, et al.
Substance use in a population-based clinic sample of people with first-episode psychosis
The British Journal of Psychiatry, June 1, 2007; 190(6): 515 - 520.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
T. R. E. BARNES, S. H. MUTSATSA, S. B. HUTTON, H. C. WATT, and E. M. JOYCE
Comorbid substance use and age at onset of schizophrenia
The British Journal of Psychiatry, March 1, 2006; 188(3): 237 - 242.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. Arendt, R. Rosenberg, L. Foldager, G. Perto, and P. Munk-Jorgensen
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases
The British Journal of Psychiatry, December 1, 2005; 187(6): 510 - 515.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
C. Henquet, R. Murray, D. Linszen, and J. van Os
The Environment and Schizophrenia: The Role of Cannabis Use
Schizophr Bull, July 1, 2005; 31(3): 608 - 612.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
D. M. Semple, A. M. McIntosh, and S. M. Lawrie
Cannabis as a risk factor for psychosis: systematic review
J Psychopharmacol, March 1, 2005; 19(2): 187 - 194.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
D. WADE
Cannabis Use and Schizophrenia
Am J Psychiatry, February 1, 2005; 162(2): 401 - 401.
[Full Text] [PDF]


Home page
JWatch PsychiatryHome page
Is Cannabis Use Associated with Earlier Onset of Schizophrenia?
Journal Watch Psychiatry, April 7, 2004; 2004(407): 5 - 5.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org